These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34440342)

  • 1. Successful Genetic Screening and Creating Awareness of Familial Hypercholesterolemia and Other Heritable Dyslipidemias in the Netherlands.
    Zuurbier LC; Defesche JC; Wiegman A
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular screening of familial hypercholesterolemia in Icelanders.
    Kellogg G; Thorsson B; Cai Y; Wisotzkey R; Pollock A; Akana M; Fox R; Jansen M; Gudmundsson EF; Patel B; Chang C; Jaremko M; Puig O; Gudnason V; Emilsson V
    Scand J Clin Lab Invest; 2020 Oct; 80(6):508-514. PubMed ID: 32706999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
    Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cascade screening and genetic diagnosis of familial hypercholesterolemia in clusters of the Southeastern region from Brazil.
    de Paiva Silvino JP; Jannes CE; Tada MT; Lima IR; Silva IFO; Pereira AC; Gomes KB
    Mol Biol Rep; 2020 Dec; 47(12):9279-9288. PubMed ID: 33231818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic testing for familial hypercholesterolemia in the Netherlands: a stepwise screening strategy enhances the mutation detection rate.
    Lombardi MP; Redeker EJ; van Gent DH; Smeele KL; Weerdesteijn R; Mannens MM
    Genet Test; 2006; 10(2):77-84. PubMed ID: 16792510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing to confirm clinical familial hypercholesterolemia.
    Reeskamp LF; Tromp TR; Defesche JC; Grefhorst A; Stroes ESG; Hovingh GK; Zuurbier L
    Eur J Prev Cardiol; 2021 Jul; 28(8):875-883. PubMed ID: 34298557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study.
    Norsworthy PJ; Vandrovcova J; Thomas ER; Campbell A; Kerr SM; Biggs J; Game L; Soutar AK; Smith BH; Dominiczak AF; Porteous DJ; Morris AD; Scotland G; Aitman TJ
    BMC Med Genet; 2014 Jun; 15():70. PubMed ID: 24956927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
    Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
    Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
    Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
    BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthomas Can Be Misdiagnosed and Mistreated in Homozygous Familial Hypercholesterolemia Patients: A Call for Increased Awareness Among Dermatologists and Health Care Practitioners.
    Alnouri F; Al-Allaf FA; Athar M; Abduljaleel Z; Alabdullah M; Alammari D; Alanazi M; Alkaf F; Allehyani A; Alotaiby MA; Alshehri A; Bouazzaoui A; Karrar H; Taher MM
    Glob Heart; 2020 Feb; 15(1):19. PubMed ID: 32489792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
    Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
    J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Children and Adolescents with Familial Hypercholesterolemia.
    Minicocci I; Pozzessere S; Prisco C; Montali A; di Costanzo A; Martino E; Martino F; Arca M
    J Pediatr; 2017 Apr; 183():100-107.e3. PubMed ID: 28161202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of Dyslipidemia and Ischemic Heart Disease.
    Sharma K; Baliga RR
    Curr Cardiol Rep; 2017 May; 19(5):46. PubMed ID: 28429242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L; Defesche J; Roeters van Lennep J
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
    Momtazi AA; Banach M; Pirro M; Stein EA; Sahebkar A
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):224-233. PubMed ID: 28534160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.
    Hooper AJ; Burnett JR; Bell DA; Watts GF
    Curr Atheroscler Rep; 2018 May; 20(6):31. PubMed ID: 29779130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal Screening for Familial Hypercholesterolemia in Children.
    Klančar G; Grošelj U; Kovač J; Bratanič N; Bratina N; Trebušak Podkrajšek K; Battelino T
    J Am Coll Cardiol; 2015 Sep; 66(11):1250-1257. PubMed ID: 26361156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.